-
Epperly Melissa B,
2023/04/30
Chief Financial Officer
459293
-94611
2023-04-30
0001725160
0001725160
364682
-
Voliotis Dimitris
2023/04/29
SVP, Clinical Development
119563
-30601
2023-04-29
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/28
1450000
-500000
2023-04-28
0001725160
0001725160
950000
-
Epperly Melissa B,
2023/04/27
Chief Financial Officer
459293
-94611
2023-04-27
0001725160
0001725160
364682
-
Voliotis Dimitris
2023/04/26
SVP, Clinical Development
119563
-30601
2023-04-26
0001725160
0001725160
88962
-
Viking Global Opportunities Illiquid Investments Sub-Master LP
2023/04/25
1450000
-500000
2023-04-25
0001725160
0001725160
950000
-
Voliotis Dimitris
2023/04/24
SVP, Clinical Development
119563
-30601
2023-04-24
0001725160
0001725160
88962
-
Epperly Melissa B,
2023/04/23
Chief Financial Officer
459293
-94611
2023-04-23
0001725160
0001725160
364682
-
Epperly Melissa B,
2023/04/22
Chief Financial Officer
459293
-94611
2023-04-22
0001725160
0001725160
364682
-
Voliotis Dimitris
2023/04/21
SVP, Clinical Development
119563
-30601
2023-04-21
0001725160
0001725160
88962